Christopher S. Meldrum
Directeur Général chez Arcato Laboratories, Inc.
Profil
Christopher S.
Meldrum was the founder of Exigent Pharmaceuticals, Inc. founded in 2007 where he held the title of Acting President.
He is currently the President & Chief Executive Officer at Arcato Laboratories, Inc. and President & Director at Avicenna Biosciences, Inc. Mr. Meldrum's former positions include President, Chief Executive Officer & Director at Pique Therapeutics, Inc., Chairman at Kylin Therapeutics, Inc., and Director at Cogenics Icoria, Inc. He was also the Managing Director at Golden Pine Ventures LLC from 2004 to 2019.
Additionally, he held the position of Secretary & Director at Catena Pharmaceuticals, Inc. from 2012 to 2013.
Mr. Meldrum's education history includes an undergraduate degree from the University of Utah and an MBA from the University of Minnesota.
Postes actifs de Christopher S. Meldrum
| Sociétés | Poste | Début |
|---|---|---|
Arcato Laboratories, Inc.
 Arcato Laboratories, Inc. Medical SpecialtiesHealth Technology Arcato Laboratories, Inc. develops, produces and commercializes oral healthcare products. It offers OraWax, a wax-based proprietary formulation that has an over-the-counter anesthetic incorporated into its matrix so as to provide sustained relief from the discomfort. The company was founded on 2011 by Michael Jay and is headquartered in Durham, NC. | Directeur Général | - |
Avicenna Biosciences, Inc.
 Avicenna Biosciences, Inc. BiotechnologyHealth Technology Avicenna Biosciences, Inc. is a biotechnology company that focuses on redesigning and optimizing drug candidates. The company is based in Durham, NC. | President | - |
Anciens postes connus de Christopher S. Meldrum
| Sociétés | Poste | Fin |
|---|---|---|
Golden Pine Ventures LLC
 Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC is an Venture Capital firm founded in 2004. The firm is headquartered in Durham. | Private Equity Investor | 01/07/2019 |
Catena Pharmaceuticals, Inc.
 Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Catena Pharmaceuticals, Inc. is focused on the development and commercialization of novel GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's proprietary chemistry is uniquely capable of affecting a specific class of GPCRs known to be relevant in a variety of disease states. Catena focuses its research and product development efforts around manipulation of the biology of the blood-borne signaling molecule lysophosphatidic acid (LPA). Its products will either block the signaling of LPA, or reduce production of LPA, or mimic LPA. The company was founded by Kevin Lynch and Tim MacDonald in the year 2008 and is headquartered in Durham, NC. | Directeur/Membre du Conseil | 09/07/2013 |
Kylin Therapeutics, Inc.
 Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kylin Therapeutics, Inc., a cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called 'pRNA' to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. This visionary platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome the most significant challenges in the development of RNA-based therapies. The formation of Kylin Therapeutics Inc., is a result of a joint partnership between IN-vivo Ventures, LLC, and Golden Pine Ventures, LLC. Together, these two companies can leverage their alliance partners and strong Board of Directors to ensure Kylin's success. A lean, cross-functional management team is set to effect early stage success. This team provides the essential ingredients to develop and promote Kylin to the next level. It is the goal of this team to provide early stage validation and market traction to attract world-class operational management with relevant credentials, track records, and operational experience. | Président | 01/07/2013 |
| Purdue University | Corporate Officer/Principal | - |
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Corporate Officer/Principal | - |
Formation de Christopher S. Meldrum
| University of Minnesota | Masters Business Admin |
| University of Utah | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kylin Therapeutics, Inc., a cutting-edge biotechnology company, employs a revolutionary RNA nanoparticle technology platform called 'pRNA' to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. This visionary platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics. The unique capabilities of the platform have enabled Kylin to overcome the most significant challenges in the development of RNA-based therapies. The formation of Kylin Therapeutics Inc., is a result of a joint partnership between IN-vivo Ventures, LLC, and Golden Pine Ventures, LLC. Together, these two companies can leverage their alliance partners and strong Board of Directors to ensure Kylin's success. A lean, cross-functional management team is set to effect early stage success. This team provides the essential ingredients to develop and promote Kylin to the next level. It is the goal of this team to provide early stage validation and market traction to attract world-class operational management with relevant credentials, track records, and operational experience. | Commercial Services |
Golden Pine Ventures LLC
Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC is an Venture Capital firm founded in 2004. The firm is headquartered in Durham. | Finance |
Pique Therapeutics, Inc.
 Pique Therapeutics, Inc. BiotechnologyHealth Technology Pique Therapeutics, Inc. develops therapeutic vaccines for the treatment of cancer. It focused on the development of new therapies to treat non-small cell lung, pancreatic, colorectal, head and neck cancer. The company was founded by Eckhard R. Podack in 2005 and is headquartered in Durham, NC. | Health Technology |
Catena Pharmaceuticals, Inc.
Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Catena Pharmaceuticals, Inc. is focused on the development and commercialization of novel GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's proprietary chemistry is uniquely capable of affecting a specific class of GPCRs known to be relevant in a variety of disease states. Catena focuses its research and product development efforts around manipulation of the biology of the blood-borne signaling molecule lysophosphatidic acid (LPA). Its products will either block the signaling of LPA, or reduce production of LPA, or mimic LPA. The company was founded by Kevin Lynch and Tim MacDonald in the year 2008 and is headquartered in Durham, NC. | Health Technology |
Exigent Pharmaceuticals, Inc.
 Exigent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Exigent Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. It focuses on the treatment and prevention of bacterial and infectious diseases. The firm seeks to discover and develop new pharmaceuticals to treat bacterial infections using its proprietary technology platform. The company was founded on May 23, 2007 and is headquartered in Durham, NC. | Health Technology |
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Commercial Services |
Arcato Laboratories, Inc.
Arcato Laboratories, Inc. Medical SpecialtiesHealth Technology Arcato Laboratories, Inc. develops, produces and commercializes oral healthcare products. It offers OraWax, a wax-based proprietary formulation that has an over-the-counter anesthetic incorporated into its matrix so as to provide sustained relief from the discomfort. The company was founded on 2011 by Michael Jay and is headquartered in Durham, NC. | Health Technology |
Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc. BiotechnologyHealth Technology Avicenna Biosciences, Inc. is a biotechnology company that focuses on redesigning and optimizing drug candidates. The company is based in Durham, NC. | Health Technology |
